CAR T-Cell Therapy: An Expert Weighs the Risks and Benefits

Published on

Topics include: Treatment and Understanding

CAR-T cell therapy has emerged as an exciting immunotherapy yielding promising results in some areas of cancer care. Could it be an option for chronic lymphocytic leukemia (CLL) patients? On location at CLL Live in Niagara Falls, Canada, CLL expert Dr. Nicole Lamanna, from Columbia University Medical Center, gives an expert perspective from clinical trial evidence on the current and future status of CAR T-cell therapy for CLL. Dr. Lamanna discusses who it’s approved for, potential toxicities, and what’s critically needed to improve the success of the novel therapeutic approach. Watch now to learn more.

 

View more programs featuring and

Transcript

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

Andrew Schorr:         

There are, yes.  Yes.  And there are toxicities with CAR-T cells.  But I think the more—the more that we're using this in general, just like anything else there's a learning curve, and so certainly as we get better dealing with potential toxicities in CAR T-cell therapy and know how to handle them better it will go smoother.  So that's I think requires just a little bit of a learning curve. 

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

Related Programs

CAR T-Cell Therapy News From ASH 2017

What news on CAR-T cell therapy was released at ASH 2017? Tune in to find out the latest.

Published:

What Factors Could Exclude Me From a Clinical Trial?

Our CLL expert panel discusses the inclusion and exclusion criteria for clinical trials. Tune in to learn more about participating in the future of CLL treatments.

Published:

Who Will Benefit From CAR T-Cell Therapy?

Tune in to find out from our panel of experts what conditions are suited for CAR T-cell therapy, the duration of the results, and where the treatment fits on your journey with CLL.

Published:

Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on June 21, 2018